Cargando…
Model of Tumor Dormancy/Recurrence after Short-Term Chemotherapy
Although many tumors regress in response to neoadjuvant chemotherapy, residual tumor cells are detected in most cancer patients post-treatment. These residual tumor cells are thought to remain dormant for years before resuming growth, resulting in tumor recurrence. Considering that recurrent tumors...
Autores principales: | Li, Shenduo, Kennedy, Margaret, Payne, Sturgis, Kennedy, Kelly, Seewaldt, Victoria L., Pizzo, Salvatore V., Bachelder, Robin E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4028269/ https://www.ncbi.nlm.nih.gov/pubmed/24845582 http://dx.doi.org/10.1371/journal.pone.0098021 |
Ejemplares similares
-
Chemotherapy enriches for an invasive triple-negative breast tumor cell subpopulation expressing a precursor form of N-cadherin on the cell surface
por: Nelson, Erik R., et al.
Publicado: (2016) -
Adipose stem cell crosstalk with chemo-residual breast cancer cells: implications for tumor recurrence
por: Lyes, Matthew A., et al.
Publicado: (2018) -
Nuclear basic fibroblast growth factor regulates triple-negative breast cancer chemo-resistance
por: Li, Shenduo, et al.
Publicado: (2015) -
Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells
por: Mo, Lihong, et al.
Publicado: (2015) -
Tumor dormancy and disease recurrence
por: Kirkland, James L.
Publicado: (2023)